Atlantic Edge Private Wealth Management, LLC Repligen Corp Transaction History
Atlantic Edge Private Wealth Management, LLC
- $323 Billion
- Q4 2024
A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 15 shares of RGEN stock, worth $2,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$2,428
Previous $2.23 Million
3.27%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
476Shares Held
54.5MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.23 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.04 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$817 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$263 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$230 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.99B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....